Physician

Daniel Sadowski, M.D.

According to 2025 Medicare claims, Daniel Sadowski, M.D. (NPI: 1376958637) practices urology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is ROCKFORD UROLOGICAL ASSOCIATES, LTD. (NPI: 1194786558; TIN: 36-2736715) and primary practice location at 61107-5298. Sadowski is affiliated with the OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Sadowski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 4,785 HCPCS/CPT codes, and received $201,213 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,969 prescription claims across 554 beneficiaries totaling $463,820 in drug costs, led by Xtandi (Enzalutamide). DME data shows 20 claims. Open Payments data shows 26 records totaling $501. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,556 to $463,820. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	217	1,122	$55,217
2020	519	4,939	$200,969
2021	624	7,172	$246,620
2022	549	3,553	$174,953
2023	607	3,498	$174,908
2024	526	4,785	$201,213

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	70	125	$1,556
2016	121	223	$6,339
2017	96	232	$12,219
2018	73	111	$9,995
2019	105	173	$21,732
2020	293	895	$207,156
2021	418	1,410	$494,374
2022	459	1,655	$695,662
2023	511	1,778	$631,003
2024	554	1,969	$463,820

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	17	$10,314
2021	N/R	67	$29,498
2022	N/R	51	$21,833
2023	N/R	33	$10,012
2024	N/R	20	$18,392

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	190	230	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	164	197	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	130	$12
51798	Ultrasound measurement of bladder capacity after voiding	115	131	$7
81003	Automated urinalysis test	276	386	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	17	510	$245,693
Thiola Ec	Tiopronin	12	360	$60,868
Myrbetriq	Mirabegron	97	3,914	$57,455
Abiraterone Acetate	Abiraterone Acetate	29	870	$37,090
Gemtesa	Vibegron	30	1,680	$27,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	20	$18,392

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$501	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Sadowski, M.D.?

Tedicare shows public-source Medicare data for Daniel Sadowski, M.D. (NPI 1376958637), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Sadowski, M.D. have ACO affiliation data?

Daniel Sadowski, M.D. is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Daniel Sadowski, M.D.?

Daniel Sadowski, M.D. is linked to ROCKFORD UROLOGICAL ASSOCIATES, LTD. (billing NPI 1194786558) in the available physician profile data.

Does Daniel Sadowski, M.D. have Open Payments data?

Daniel Sadowski, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.